By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TransForm Pharmaceuticals, Inc. 

29 Hartwell Avenue

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-674-8000 Fax: 781-863-6519

TransForm Pharmaceuticals brings new value to products by reinventing the industry’s approach to form and formulation, with deep scientific expertise in form and formulation, state-of-art high-throughput experimentation and informatics to maximize the clinical and commercial value. TransForm is distinctively positioned to expedite drug development to bring new and better products to the market, and the patients we ultimately serve.

Key Statistics

Ownership: Private

Web Site: TransForm Pharmaceuticals, Inc.


Start Up

Company News
Johnson & Johnson (JNJ) Completes Acquisition Of TransForm Pharmaceuticals, Inc.10/19/2005 5:13:12 PM
Mintz Levin Counsels TransForm Pharmaceuticals, Inc. In Acquisition10/19/2005 5:13:03 PM
Johnson & Johnson (JNJ) To Acquire TransForm Pharmaceuticals, Inc.10/19/2005 5:12:57 PM
TransForm Pharmaceuticals, Inc. Receives Milestone Payment From AstraZeneca (AZN)10/19/2005 5:12:20 PM
TransForm Pharmaceuticals, Inc. Initiates Phase II Clinical Trial For A CNS Drug10/19/2005 5:12:11 PM
TransForm Pharmaceuticals, Inc. Announces Collaboration With Abbott Laboratories (ABT) To Enhance Drug Development Programs10/19/2005 5:11:36 PM
TransForm Pharmaceuticals, Inc. Announces Agreement With Eli Lilly and Company (LLY); Collaboration To Improve Preclinical Formulation Screening10/19/2005 5:11:27 PM
TransForm Pharmaceuticals, Inc. And University of South Florida Announce Collaboration To Improve Drug Performance Through Co-crystals10/19/2005 5:11:06 PM
TransForm Pharmaceuticals, Inc. Announces New President, Paul D. Goldenheim, M.D.10/19/2005 5:11:05 PM
TransForm Pharmaceuticals, Inc. Announces Product Deal With Fort Dodge Animal Health; Outlicenses Proprietary Formulation Of An Anesthetic For Veterinary Use10/19/2005 5:10:39 PM